Home > Newsletters > Drug Industry Daily > Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring
Drug Industry Daily
July 18, 2012 | Vol. 11 No. 140
Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring
Lawmakers and watchdog groups are putting a brighter spotlight on the FDA, demanding the agency, HHS and White House take action to ensure whistleblower protections and investigate allegations of inappropriate email monitoring by the drug regulator.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.